ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM

[1]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[2]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[3]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[4]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[5]  H. Vanderstichele,et al.  Release of endothelium-derived relaxing factor from human umbilical vessels. , 1987, Circulation research.

[6]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[7]  P. Sever,et al.  Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro. , 1985, Clinical science.

[8]  P. Angelberger,et al.  Platelet labeling with in-111 oxine: benefit of prostacyclin (PgI2)--addition for preparation and injection. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.

[10]  F. Roughton,et al.  The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin , 1957, The Journal of physiology.